An application to vary the product licence for Hemofil was approved on 13 June 1975, allowing for the use of radioimmunoassay ("RIA") testing for Hepatitis B antigen.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates